4//SEC Filing
Androski Lindsay 4
Accession 0001104659-24-007291
CIK 0001035354other
Filed
Jan 25, 7:00 PM ET
Accepted
Jan 26, 4:32 PM ET
Size
6.1 KB
Accession
0001104659-24-007291
Insider Transaction Report
Form 4
Androski Lindsay
Director
Transactions
- Award
Restricted Stock Units
2024-01-24+7,500→ 7,500 total→ Common Stock (7,500 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
- [F2]The RSUs vest as to 50% on the first anniversary of January 24, 2024 and, as to the remaining amount, in two equal annual installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date.
Documents
Issuer
Eloxx Pharmaceuticals, Inc.
CIK 0001035354
Entity typeother
Related Parties
1- filerCIK 0001936604
Filing Metadata
- Form type
- 4
- Filed
- Jan 25, 7:00 PM ET
- Accepted
- Jan 26, 4:32 PM ET
- Size
- 6.1 KB